2006
DOI: 10.1182/blood-2005-06-2284
|View full text |Cite
|
Sign up to set email alerts
|

Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
181
0
3

Year Published

2008
2008
2022
2022

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 248 publications
(193 citation statements)
references
References 45 publications
7
181
0
3
Order By: Relevance
“…Published studies have shown that the ALDH1 bright / CD133 positive cells contain both short and long term repopulating human HSCs and in contrast to ALDH1 bright /CD133 negative , cells have faster engraftment and repopulation capacity (7). Our data confirms published studies showing that most ALDH1 bright /SSC low cells display phenotypic markers of primitive hematopoietic cells, that is, CD34, CD117, and CD133 (7,11,13).…”
Section: Correlation Of Marker Expression In Cells From Hpc-a Samplessupporting
confidence: 81%
See 2 more Smart Citations
“…Published studies have shown that the ALDH1 bright / CD133 positive cells contain both short and long term repopulating human HSCs and in contrast to ALDH1 bright /CD133 negative , cells have faster engraftment and repopulation capacity (7). Our data confirms published studies showing that most ALDH1 bright /SSC low cells display phenotypic markers of primitive hematopoietic cells, that is, CD34, CD117, and CD133 (7,11,13).…”
Section: Correlation Of Marker Expression In Cells From Hpc-a Samplessupporting
confidence: 81%
“…ALDH1 dim cells from human cord blood can initiate short-term progenitors in mice xenograft models, whereas the ALDH1 bright cells can initiate long-term cultures and grow as xenografts (10). Hess et al (7) reported that in human cord blood, ALDH1 bright / CD34 negative cells might represent a primitive progenitor population, whereas Mirabelli et al (13) reported that in human bone marrow ALDH1 bright /CD34 negative , Figure 3A shows that 0.13% of the cells had CD34 bright and CD90 mid expression (gate R3) while in contrast 0.11% of the cells were CD34 bright with CD90 negative expression (gate R5). Dot plot 3B shows that 0.25% of the cells had CD34 bright and CD117 dim-bright expression while 0.30% of the cells had CD34 dim and CD117 dim expression (gate R4) or 0.12% of the cells had CD34 negative and CD117 dim expression (gate R5).…”
Section: Figmentioning
confidence: 88%
See 1 more Smart Citation
“…Thus, ALDH1A1-expressing cells have a crucial role in the initiation and progression of esophageal squamous cell carcinoma. ALDH1A1 is a predominant isoform of aldehyde dehydrogenase family in mammals located in the cytoplasm 15,16 and is originally considered as a marker for normal hematopoietic progenitor cells, 17 and is also found in cancer cells with stem cell property, that is, cancer stem-like cells, in several malignant tumors including leukemia, 9 breast cancer 7 and lung cancer. 8,18 Wang et al 19 reported that ALDH1A1 was located in the nuclei of esophageal squamous cell carcinoma cells.…”
Section: Discussionmentioning
confidence: 99%
“…HSCs with long-term repopulating ability have been identified in bone marrow and cord blood, based on the combined expression of CD34 and ALDH [51,52]. High ALDH expression has also been combined with CD133 to select for human HSCs from bone marrow [78]. Sca-1 (stem cell antigen 1, Ly-6A/E) is an 18 kDa phosphatidylinositol-anchored protein expressed on murine multipotent HSCs, and is frequently used in combination with negative-selection for a number of cell surface markers characteristic of commitment toward haematolymphoid lineages (Lin − ).…”
Section: Bone Marrowmentioning
confidence: 99%